The discovery of ALK dates back to 1994 when a chromosomal rearrangement, t(2;5), resulting in a nucleophosmin (NPM1)–ALK fusion was described in anaplastic large-cell lymphoma [89]. The gene discussed is NPM1; the disease is anaplastic large cell lymphoma.